CN113710258A - Prpf31基因表达敲低提高体外分化的人细胞的存活 - Google Patents
Prpf31基因表达敲低提高体外分化的人细胞的存活 Download PDFInfo
- Publication number
- CN113710258A CN113710258A CN202080030633.0A CN202080030633A CN113710258A CN 113710258 A CN113710258 A CN 113710258A CN 202080030633 A CN202080030633 A CN 202080030633A CN 113710258 A CN113710258 A CN 113710258A
- Authority
- CN
- China
- Prior art keywords
- cells
- nucleic acid
- differentiated
- agent
- prpf31
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/65—MicroRNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818979P | 2019-03-15 | 2019-03-15 | |
| US62/818,979 | 2019-03-15 | ||
| PCT/US2020/022679 WO2020190739A1 (en) | 2019-03-15 | 2020-03-13 | Improved survival of human cells differentiated in vitro by prpf31 gene expression knockdown |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113710258A true CN113710258A (zh) | 2021-11-26 |
Family
ID=72520464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080030633.0A Pending CN113710258A (zh) | 2019-03-15 | 2020-03-13 | Prpf31基因表达敲低提高体外分化的人细胞的存活 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220152278A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3937956A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022525193A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113710258A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020241251A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3129782A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020190739A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4356931A4 (en) * | 2021-06-16 | 2025-07-16 | Chigenovo Co Ltd | VARIANT OF PRPF31 AND ITS USE |
| US20250082689A1 (en) * | 2021-07-21 | 2025-03-13 | University Of Washington | Compositions and methods for enhancing cardiomyocyte transplant engraftment |
| WO2024086352A2 (en) * | 2022-10-21 | 2024-04-25 | Biogen Ma Inc. | Compositions and methods for treating retinitis pigmentosa |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140328825A1 (en) * | 2011-12-30 | 2014-11-06 | Cellscript, Llc | MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT |
| WO2018078301A1 (fr) * | 2016-10-28 | 2018-05-03 | Université Pierre Et Marie Curie - Paris 6 (Upmc) | Procédé de différenciation de cellules souches pluripotentes en cardiomyocytes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| US7875451B2 (en) * | 2006-01-19 | 2011-01-25 | The University Of Washington | Formulation to improve survival of transplanted cells |
| AU2008204541B2 (en) * | 2007-01-09 | 2014-07-10 | Lead Pharma Cel Models Ip B.V. | Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom |
| US9213999B2 (en) * | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
| JP2011512326A (ja) * | 2007-12-31 | 2011-04-21 | ナノコア セラピューティクス,インコーポレイテッド | 心不全の治療用のrna干渉 |
| US8993318B2 (en) * | 2009-12-11 | 2015-03-31 | The Brigham And Women's Hospital, Inc. | Pathogen restriction factors |
| US20180043034A1 (en) * | 2015-03-06 | 2018-02-15 | Massachusetts Eye And Ear Infirmary | Gene augmentation therapies for inherited retinal degeneration caused by mutations in the prpf31 gene |
| US11752176B2 (en) * | 2017-03-15 | 2023-09-12 | University Of Washington | Methods and compositions for enhancing cardiomyocyte maturation and engraftment |
-
2020
- 2020-03-13 JP JP2021555433A patent/JP2022525193A/ja active Pending
- 2020-03-13 CA CA3129782A patent/CA3129782A1/en active Pending
- 2020-03-13 US US17/439,482 patent/US20220152278A1/en not_active Abandoned
- 2020-03-13 EP EP20774782.5A patent/EP3937956A4/en not_active Withdrawn
- 2020-03-13 CN CN202080030633.0A patent/CN113710258A/zh active Pending
- 2020-03-13 WO PCT/US2020/022679 patent/WO2020190739A1/en not_active Ceased
- 2020-03-13 AU AU2020241251A patent/AU2020241251A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140328825A1 (en) * | 2011-12-30 | 2014-11-06 | Cellscript, Llc | MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT |
| WO2018078301A1 (fr) * | 2016-10-28 | 2018-05-03 | Université Pierre Et Marie Curie - Paris 6 (Upmc) | Procédé de différenciation de cellules souches pluripotentes en cardiomyocytes |
Non-Patent Citations (1)
| Title |
|---|
| LEILA AZIZZADEH PORMEHR等: "Human organotypic retinal flat-mount culture (HORFC) as a model for retinitis pigmentosa11", J CELL BIOCHEM, vol. 119, no. 8, pages 6775 - 6783 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020190739A1 (en) | 2020-09-24 |
| EP3937956A1 (en) | 2022-01-19 |
| US20220152278A1 (en) | 2022-05-19 |
| EP3937956A4 (en) | 2022-12-28 |
| AU2020241251A1 (en) | 2021-10-07 |
| CA3129782A1 (en) | 2020-09-24 |
| JP2022525193A (ja) | 2022-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner | |
| JP2019201631A (ja) | 治療用微小胞と幹細胞の合成 | |
| US8815593B2 (en) | Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling | |
| CN102459576B (zh) | 用于调节干细胞的组合物和方法及其应用 | |
| US20240368541A1 (en) | Methods of generating mature corneal endothelial cells | |
| JP2011522520A (ja) | 細胞の脱分化を行う方法 | |
| US10443044B2 (en) | Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds | |
| US20250216377A1 (en) | Compositions and methods for detecting cardiotoxicity | |
| JP5921558B2 (ja) | 心臓人工多能性幹細胞ならびに心筋の修復および再生に使用する方法 | |
| US20220152278A1 (en) | Improved survival of human cells differentiated in vitro by prpf31 gene expression knockdown | |
| US20180042969A1 (en) | Compositions and methods for the reprogramming of cells into cardiomyocytes | |
| US20130202649A1 (en) | Activation of innate immunity for nuclear reprogramming of somatic cells | |
| WO2011031875A2 (en) | Cell-based compositions and uses thereof | |
| US20220213444A1 (en) | Compositions and methods for cellular reprogramming | |
| WO2017177050A1 (en) | Direct reprogramming of somatic cells into myogenic cells | |
| US20240392252A1 (en) | Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds | |
| CN117500940A (zh) | 原钙粘蛋白在诊断和治疗癌症的方法中的用途 | |
| US12173322B2 (en) | Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof | |
| WO2020190939A1 (en) | Methods of promoting cellular maturation with ampk activators | |
| US20240158788A1 (en) | Methods and compositions used to modify chromatin architecture to regulate phenotype in aging and cancer | |
| Sottile | Mesenchymal stem cells generate distinc functional hybrids via cell fusion or entosis | |
| HK40096970A (en) | Methods of generating mature corneal endothelial cells | |
| WO2023070130A2 (en) | Mirna reprogramming of smooth muscle cells into endothelial cells | |
| Buccini | Cardiogenic differentiation of induced pluripotent stem cells for regeneration of the ischemic heart | |
| Cassano et al. | CT-0507 Accepted 10/21/2011 for publication in “Cell Transplantation” |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211126 |
|
| WD01 | Invention patent application deemed withdrawn after publication |